By Professor David Simon Ziegler

Journal articles

Mazariego CG; McKay S; Tyedmers E; Kelada L; McGill BC; Daly R; Wakefield CE; Ziegler DS; Taylor N; Mazariego-Jones C, 2024, 'Co-design of a paediatric oncology medicines database (ProCure) to support complex care provision for children with a hard-to-treat cancer', Frontiers in Medicine, 11, pp. 1332434, http://dx.doi.org/10.3389/fmed.2024.1332434

Upton DH; Ziegler DS; Tsoli M, 2024, 'Development of Orthotopic Patient-Derived Xenograft Models of Pediatric Intracranial Tumors', , 2806, pp. 75 - 90, http://dx.doi.org/10.1007/978-1-0716-3858-3_7

Rouleau G; Wu K; Ramamoorthi K; Boxall C; Liu RH; Maloney S; Zelmer J; Scott T; Larsen D; Wijeysundera HC; Ziegler D; Bhatia S; Kishimoto V; Gray CS; Desveaux L, 2024, 'Mapping Theories, Models, and Frameworks to Evaluate Digital Health Interventions: Scoping Review', Journal of Medical Internet Research, 26, http://dx.doi.org/10.2196/51098

Chen Y; Khan A; Katsinas C; Michniewicz F; Goldberg J; Franshaw L; Tsoli M; Ziegler DS, 2024, 'Preclinical evaluation of protein synthesis inhibitor omacetaxine in pediatric brainstem gliomas', Neuro Oncology Advances, 6, http://dx.doi.org/10.1093/noajnl/vdae029

Kilburn LB; Khuong-Quang DA; Hansford JR; Landi D; van der Lugt J; Leary SES; Driever PH; Bailey S; Perreault S; McCowage G; Waanders AJ; Ziegler DS; Witt O; Baxter PA; Kang HJ; Hassall TE; Han JW; Hargrave D; Franson AT; Yalon Oren M; Toledano H; Larouche V; Kline C; Abdelbaki MS; Jabado N; Gottardo NG; Gerber NU; Whipple NS; Segal D; Chi SN; Oren L; Tan EEK; Mueller S; Cornelio I; McLeod L; Zhao X; Walter A; Da Costa D; Manley P; Blackman SC; Packer RJ; Nysom K, 2024, 'The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial', Nature Medicine, 30, pp. 207 - 217, http://dx.doi.org/10.1038/s41591-023-02668-y

Hetherington K; Wakefield CE; McGill BC; Tucker KM; Donoghoe MW; Daly R; Hunter JD; Ballinger M; Fuentes-Bolanos NA; Ziegler DS, 2024, 'When genetics and pediatric cancer collide: Understanding and optimizing families' experiences', Neuro Oncology Advances, 6, http://dx.doi.org/10.1093/noajnl/vdae133

Mayoh C; Gifford AJ; Terry R; Lau LMS; Wong M; Rao P; Shai-Hee T; Saletta F; Khuong-Quang DA; Qin V; Mateos MK; Meyran D; Miller KE; Yuksel A; Mould EVA; Bowen-James R; Govender D; Senapati A; Zhukova N; Omer N; Dholaria H; Alvaro F; Tapp H; Diamond Y; Pozza LD; Moore AS; Nicholls W; Gottardo NG; McCowage G; Hansford JR; Khaw SL; Wood PJ; Catchpoole D; Cottrell CE; Mardis ER; Marshall GM; Tyrrell V; Haber M; Ziegler DS; Vittorio O; Trapani JA; Cowley MJ; Neeson PJ; Ekert PG, 2023, 'A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer', Genome Medicine, 15, http://dx.doi.org/10.1186/s13073-023-01170-x

Poursani EM; Mercatelli D; Raninga P; Bell JL; Saletta F; Kohane FV; Neumann DP; Zheng Y; Rouaen JRC; Jue TR; Michniewicz FT; Schadel P; Kasiou E; Tsoli M; Cirillo G; Waters S; Shai-Hee T; Cazzoli R; Brettle M; Slapetova I; Kasherman M; Whan R; Souza-Fonseca-Guimaraes F; Vahdat L; Ziegler D; Lock JG; Giorgi FM; Khanna KK; Vittorio O, 2023, 'Copper chelation suppresses epithelial-mesenchymal transition by inhibition of canonical and non-canonical TGF-β signaling pathways in cancer', Cell and Bioscience, 13, pp. 132, http://dx.doi.org/10.1186/s13578-023-01083-7

Ajuyah P; Mayoh C; Lau LMS; Barahona P; Wong M; Chambers H; Valdes-Mora F; Senapati A; Gifford AJ; D’Arcy C; Hansford JR; Manoharan N; Nicholls W; Williams MM; Wood PJ; Cowley MJ; Tyrrell V; Haber M; Ekert PG; Ziegler DS; Khuong-Quang DA; Valdes Mora F, 2023, 'Histone H3-wild type diffuse midline gliomas with H3K27me3 loss are a distinct entity with exclusive EGFR or ACVR1 mutation and differential methylation of homeobox genes', Scientific Reports, 13, pp. 3775, http://dx.doi.org/10.1038/s41598-023-30395-4

Kummar S; Shen L; Hong DS; McDermott R; Keedy VL; Casanova M; Demetri GD; Dowlati A; Melcón SG; Lassen UN; Leyvraz S; Liu T; Moreno V; Patel J; Patil T; Mallick AB; Sousa N; Tahara M; Ziegler DS; Norenberg R; Arvis P; Brega N; Drilon A; Tan DSW, 2023, 'Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas', Cancer, 129, pp. 3772 - 3782, http://dx.doi.org/10.1002/cncr.35036

Gereis JM; Hetherington K; Robertson EG; Daly R; Donoghoe MW; Ziegler DS; Marshall GM; Lau LMS; Marron JM; Wakefield CE, 2023, 'Parents’ and adolescents’ perspectives and understanding of information about childhood cancer precision medicine', Cancer, 129, pp. 3645 - 3655, http://dx.doi.org/10.1002/cncr.34914

McGill BC; Wakefield CE; Tucker KM; Daly RA; Donoghoe MW; Vetsch J; Warby M; Fuentes-Bolanos NA; Barlow-Stewart K; Kirk J; Courtney E; O’Brien TA; Marshall GM; Pinese M; Cowley MJ; Tyrrell V; Deyell RJ; Ziegler DS; Hetherington K, 2023, 'Parents’ expectations, preferences, and recall of germline findings in a childhood cancer precision medicine trial', Cancer, 129, pp. 3620 - 3632, http://dx.doi.org/10.1002/cncr.34917

Lehmann R; Zhu J; Mayoh C; Tsoli M; Rayner B; Ziegler D, 2023, 'DDDR-30. IDENTIFICATION OF DRIVERS OF RESISTANCE IN BRAFV600E PEDIATRIC HIGH-GRADE GLIOMA AND NOVEL THERAPEUTIC TARGETS', Neuro-Oncology, 25, pp. v112 - v112, http://dx.doi.org/10.1093/neuonc/noad179.0423

Ung C; Upton D; Venkat P; Pandher R; Mayoh C; Tsoli M; Ziegler D, 2023, 'DDEL-07. BARRIER TO PROGRESS: DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) INDUCES A TIGHTENED BLOOD-BRAIN BARRIER PHENOTYPE', Neuro-Oncology, 25, pp. v102 - v103, http://dx.doi.org/10.1093/neuonc/noad179.0386

Wakefield CE; Hetherington K; Robertson EG; Donoghoe MW; Hunter JD; Vetsch J; Marron JM; Tucker KM; Marshall GM; Broom A; Haber M; Tyrrell V; Malkin D; Lau L; Mateos MK; O’Brien TA; Ziegler DS, 2023, 'Hopes, concerns, satisfaction and regret in a precision medicine trial for childhood cancer: a mixed-methods study of parent and patient perspectives', British Journal of Cancer, 129, pp. 1634 - 1644, http://dx.doi.org/10.1038/s41416-023-02429-1

Grebstad Tune B; Sareen H; Powter B; Kahana-Edwin S; Cooper A; Koh ES; Lee CS; Po JW; McCowage G; Dexter M; Cain L; O’Neill G; Prior V; Karpelowsky J; Tsoli M; Baumbusch LO; Ziegler D; Roberts TL; DeSouza P; Becker TM; Ma Y, 2023, 'From Pediatric to Adult Brain Cancer: Exploring Histone H3 Mutations in Australian Brain Cancer Patients', Biomedicines, 11, http://dx.doi.org/10.3390/biomedicines11112907

Hardin EC; Schmid S; Sommerkamp A; Bodden C; Heipertz AE; Sievers P; Wittmann A; Milde T; Pfister SM; von Deimling A; Horn S; Herz NA; Simon M; Perera AA; Azizi A; Cruz O; Curry S; Van Damme A; Garami M; Hargrave D; Kattamis A; Kotnik BF; Lähteenmäki P; Scheinemann K; Schouten-Van Meeteren AYN; Sehested A; Viscardi E; Wormdal OM; Zapotocky M; Ziegler DS; Koch A; Driever PH; Witt O; Capper D; Sahm F; Jones DTW; van Tilburg CM, 2023, 'LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patients', Neuro Oncology, 25, pp. 2087 - 2097, http://dx.doi.org/10.1093/neuonc/noad078

White CL; Kinross KM; Moore MK; Rasouli E; Strong R; Jones JM; Cain JE; Sturm D; Sahm F; Jones DTW; Pfister SM; Robertson T; D'Arcy C; Rodriguez ML; Dyke JM; Junckerstorff R; Bhuva DD; Davis MJ; Wood P; Hassall T; Ziegler DS; Kellie S; McCowage G; Alvaro F; Kirby M; Heath JA; Tsui K; Dodgshun A; Eisenstat DD; Khuong-Quang DA; Wall M; Algar EM; Gottardo NG; Hansford JR, 2023, 'Implementation of DNA Methylation Array Profiling in Pediatric Central Nervous System Tumors: The AIM BRAIN Project: An Australian and New Zealand Children's Haematology/Oncology Group Study', Journal of Molecular Diagnostics, 25, pp. 709 - 728, http://dx.doi.org/10.1016/j.jmoldx.2023.06.013

Daniel P; Sun CX; Bradshaw G; Shi H; Loi M; Chew N; Parackal S; Tsui V; Liang Y; Koptyra M; Adjumain S; Sun C; Chong WC; Fernando D; Drinkwater C; Tourchi M; Habarakada D; Carvalho D; Storm PB; Baubet V; Sayles LC; Fernandez E; Zhukova N; Dun MD; Ludlow LE; Day B; Stringer BW; Neeman N; Rubens JA; Raabe EH; Vinci M; Tyrrell V; Fletcher JI; Ekert PG; Dumevska B; Ziegler DS; Tsoli M; Sulaiman NFS; Loh AHP; Low SYY; Sweet-Cordero EA; Monje M; Resnick A; Jones C; Downie P; Williams B; Rosenbluh J; Gough D; Cain JE; Firestein R, 2023, 'SYST-15 GENERATION AND MULTI-DIMENSIONAL PROFILING OF A CHILDHOOD CANCER CELL LINE ATLAS DEFINES NEW THERAPEUTIC OPPORTUNITIES', Neuro-Oncology Advances, 5, pp. iii30 - iii30, http://dx.doi.org/10.1093/noajnl/vdad070.119

Mayoh C; Mao J; Xie J; Tax G; Chow SO; Cadiz R; Pazaky K; Barahona P; Ajuyah P; Trebilcock P; Malquori A; Gunther K; Avila A; Yun DY; Alfred S; Gopalakrishnan A; Kamili A; Wong M; Cowley MJ; Jessop S; Lau LMS; Trahair TN; Ziegler DS; Fletcher JI; Gifford AJ; Tsoli M; Marshall GM; Haber M; Tyrrell V; Failes TW; Arndt GM; Lock RB; Ekert PG; M Dolman ME; Wong-Erasmus M; Ajuyah P, 2023, 'High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer', Cancer Research, 83, pp. 2716 - 2732, http://dx.doi.org/10.1158/0008-5472.CAN-22-3702

Geoerger B; Marshall LV; Nysom K; Makin G; Bouffet E; Defachelles AS; Amoroso L; Aerts I; Leblond P; Barahona P; Van-Vlerken K; Fu E; Solca F; Lorence RM; Ziegler DS, 2023, 'Afatinib in paediatric patients with recurrent/refractory ErbB-dysregulated tumours: Results of a phase I/expansion trial', European Journal of Cancer, 188, pp. 8 - 19, http://dx.doi.org/10.1016/j.ejca.2023.04.007

Daly R; Hetherington K; Hazell E; Wadling BR; Tyrrell V; Tucker KM; Marshall GM; Ziegler DS; Lau LMS; Trahair TN; O’Brien TA; Collins K; Gifford AJ; Haber M; Pinese M; Malkin D; Cowley MJ; Karpelowsky J; Drew D; Jacobs C; Wakefield CE, 2023, 'Precision Medicine Is Changing the Roles of Healthcare Professionals, Scientists, and Research Staff: Learnings from a Childhood Cancer Precision Medicine Trial', Journal of Personalized Medicine, 13, http://dx.doi.org/10.3390/jpm13071033

Kilburn L; Khuong-Quang D-A; Nysom K; Landi D; Ziegler D; Driever PH; Leary S; Bailey S; Van der Lugt J; Perreault S; Waanders A; Baxter P; Witt O; Hargrave D; McCowage G; Zhao X; Da Costa D; Cox M; Manley P; Hansford J, 2023, 'LGG-09. CLINICAL ACTIVITY OF PAN-RAF INHIBITOR TOVORAFENIB IN THE REGISTRATIONAL PEDIATRIC LOW-GRADE GLIOMA ARM OF THE PHASE 2 FIREFLY-1 (PNOC026) STUDY', Neuro-Oncology, 25, pp. i57 - i57, http://dx.doi.org/10.1093/neuonc/noad073.219

Kilburn LB; Khuong-Quang D-A; Nysom K; Landi DB; Ziegler DS; Hernáiz Driever P; Leary S; Bailey S; van der Lugt J; Perreault S; Waanders AJ; Baxter PA; Witt O; Hargrave DR; McCowage GB; Zhao X; Da Costa D; Cox MC; Manley P; Hansford J, 2023, 'Clinical activity of pan-RAF inhibitor tovorafenib in the registrational pediatric low-grade glioma arm of the phase 2 FIREFLY-1 (PNOC026) study.', Journal of Clinical Oncology, 41, pp. 10004 - 10004, http://dx.doi.org/10.1200/jco.2023.41.16_suppl.10004

van Tilburg CM; Kilburn LB; Crotty E; Smith AA; Perreault S; Franson AF; Jabado N; Hoffman LM; Schmidt R; Schouten-van Meeteren AYN; Sehestedt A; Opocher E; Hernáiz Driever P; Avula S; Ziegler DS; Qiu J; Tsao L-P; Manley P; Hargrave DR; Witt O, 2023, 'LOGGIC/FIREFLY-2: A phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration.', Journal of Clinical Oncology, 41, pp. TPS10067 - TPS10067, http://dx.doi.org/10.1200/jco.2023.41.16_suppl.tps10067

Gonzales-Aloy E; Ahmed-Cox A; Tsoli M; Ziegler DS; Kavallaris M, 2023, 'From cells to organoids: The evolution of blood-brain barrier technology for modelling drug delivery in brain cancer', Advanced Drug Delivery Reviews, 196, http://dx.doi.org/10.1016/j.addr.2023.114777

Sun CX; Daniel P; Bradshaw G; Shi H; Loi M; Chew N; Parackal S; Tsui V; Liang Y; Koptyra M; Adjumain S; Sun C; Chong WC; Fernando D; Drinkwater C; Tourchi M; Habarakada D; Sooraj D; Carvalho D; Storm PB; Baubet V; Sayles LC; Fernandez E; Nguyen T; Pörksen M; Doan A; Crombie DE; Panday M; Zhukova N; Dun MD; Ludlow LE; Day B; Stringer BW; Neeman N; Rubens JA; Raabe EH; Vinci M; Tyrrell V; Fletcher JI; Ekert PG; Dumevska B; Ziegler DS; Tsoli M; Syed Sulaiman NF; Loh AHP; Low SYY; Sweet-Cordero EA; Monje M; Resnick A; Jones C; Downie P; Williams B; Rosenbluh J; Gough D; Cain JE; Firestein R, 2023, 'Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities', Cancer Cell, 41, pp. 660 - 677.e7, http://dx.doi.org/10.1016/j.ccell.2023.03.007

Hayden E; Franshaw L; Upton D; Liu J; Nguyen H; Joshi S; Tsoli M; Dolman E; Rayner B; Ziegler D, 2023, 'Abstract 1561: Preclinical examination of PLK1 inhibitors for the treatment of diffuse midline gliomas', Cancer Research, 83, pp. 1561 - 1561, http://dx.doi.org/10.1158/1538-7445.am2023-1561

Trinder SM; McKay C; Power P; Topp M; Chan B; Valvi S; McCowage G; Govender D; Kirby M; Ziegler DS; Manoharan N; Hassall T; Kellie S; Heath J; Alvaro F; Wood P; Laughton S; Tsui K; Dodgshun A; Eisenstat DD; Endersby R; Luen SJ; Koh ES; Sim HW; Kong B; Gottardo NG; Whittle JR; Khuong-Quang DA; Hansford JR, 2023, 'BRAF-mediated brain tumors in adults and children: A review and the Australian and New Zealand experience', Frontiers in Oncology, 13, http://dx.doi.org/10.3389/fonc.2023.1154246

Whitehouse JP; Hii H; Mayoh C; Wong M; Ajuyah P; Barahona P; Cui L; Dholaria H; White CL; Buntine MK; Byrne J; Rodrigues da Silva K; Howlett M; Girard EJ; Tsoli M; Ziegler DS; Dyke JM; Lee S; Ekert PG; Cowley MJ; Gottardo NG; Endersby R, 2023, 'In vivo loss of tumorigenicity in a patient-derived orthotopic xenograft mouse model of ependymoma', Frontiers in Oncology, 13, http://dx.doi.org/10.3389/fonc.2023.1123492

Ehteda A; Khan A; Rajakumar G; Vanniasinghe AS; Gopalakrishnan A; Liu J; Tsoli M; Ziegler DS, 2023, 'Microtubule-Targeting Combined with HDAC Inhibition Is a Novel Therapeutic Strategy for Diffuse Intrinsic Pontine Gliomas', Molecular Cancer Therapeutics, 22, pp. 1413 - 1421, http://dx.doi.org/10.1158/1535-7163.MCT-23-0179

Ziegler DS, 2023, 'Pan-RAF Inhibitors for Paediatric Low-grade Gliomas Offer New Opportunities in Targeted Therapy', European Oncology and Haematology, 19, pp. 4 - 5, http://dx.doi.org/10.17925/OHR.2023.19.1.4

Staunton J; Ziegler DS, 2023, 'Temozolomide for Paediatric High-Grade Glioma: Time for a Rethink?', European Oncology and Haematology, 19, pp. 4 - 6, http://dx.doi.org/10.17925/OHR.2023.19.2.4

Lilly JV; Rokita JL; Mason JL; Patton T; Stefankiewiz S; Higgins D; Trooskin G; Larouci CA; Arya K; Appert E; Heath AP; Zhu Y; Brown MA; Zhang B; Farrow BK; Robins S; Morgan AM; Nguyen TQ; Frenkel E; Lehmann K; Drake E; Sullivan C; Plisiewicz A; Coleman N; Patterson L; Koptyra M; Helili Z; Van Kuren N; Young N; Kim MC; Friedman C; Lubneuski A; Blackden C; Williams M; Baubet V; Tauhid L; Galanaugh J; Boucher K; Ijaz H; Cole KA; Choudhari N; Santi M; Moulder RW; Waller J; Rife W; Diskin SJ; Mateos M; Parsons DW; Pollack IF; Goldman S; Leary S; Caporalini C; Buccoliero AM; Scagnet M; Haussler D; Hanson D; Firestein R; Cain J; Phillips JJ; Gupta N; Mueller S; Grant G; Monje-Deisseroth M; Partap S; Greenfield JP; Hashizume R; Smith A; Zhu S; Johnston JM; Fangusaro JR; Miller M; Wood MD; Gardner S; Carter CL; Prolo LM; Pisapia J; Pehlivan K; Franson A; Niazi T; Rubin J; Abdelbaki M; Ziegler DS; Lindsay HB; Stucklin AG; Gerber N; Vaske OM; Quinsey C; Rood BR; Nazarian J; Raabe E; Jackson EM; Stapleton S; Lober RM; Kram DE; Koschmann C; Storm PB; Lulla RR; Prados M; Resnick AC; Waanders AJ, 2023, 'The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science', Neoplasia United States, 35, http://dx.doi.org/10.1016/j.neo.2022.100846

Murray J; Pandher R; Xiao L; Somers K; Brand J; Mosmann E; Alfred S; Kusuma F; Keams A; Park JR; Marshall LV; Gorrini C; Chesler L; Hogarty MD; Pearson ADJ; Burns M; Fletcher JI; Ziegler D; Norris MD; Haber M, 2023, 'Addition of AMXT1501 (polyamine uptake inhibitor) plus DFMO (polyamine synthesis inhibitor) to standard-of-care chemotherapy/anti-GD2 antibody in the TH-MYCN mouse neuroblastoma model, enhances efficacy compared to addition of DFMO alone', MOLECULAR CANCER THERAPEUTICS, 22, http://dx.doi.org/10.1158/1535-7163.TARG-23-B132

Staunton J; Robertson PA; Harris A; Mayoh C; Wong M; Rumford M; Fuentes-Bolanos N; Cowley M; Lau L; Ziegler DS; Barahona P; Manoharan N, 2023, 'NOVEL PAEDIATRIC CASE OF A SPINAL HIGH-GRADE ASTROCYTOMA WITH PILOID FEATURES IN A PATIENT WITH NOONAN SYNDROME', NEURO-ONCOLOGY, 25, http://dx.doi.org/10.1093/neuonc/noad073.169

Lehmann R; Rayner BS; Ziegler DS, 2022, 'Resistance mechanisms in BRAFV600E paediatric high-grade glioma and current therapeutic approaches', Frontiers in Oncology, 12, http://dx.doi.org/10.3389/fonc.2022.1031378

Bartlett AL; Lane A; Chaney B; Escorza NY; Black K; Cochrane A; Minturn J; Bartels U; Warren K; Hansford J; Ziegler D; Diez B; Goldman S; Packer R; Kieran M; DeWire-Schottmiller M; Erker C; Monje-Deisseroth M; Wagner L; Koschmann C; Dorris K; Shih CS; Hassall T; Samson Y; Fisher P; Wang SS; Tsui K; Sevlever G; Zhu X; Dexheimer P; Asher A; Fuller C; Drissi R; Jones B; Leach J; Fouladi M, 2022, 'Characteristics of children ≤36 months of age with DIPG: A report from the international DIPG registry', Neuro Oncology, 24, pp. 2190 - 2199, http://dx.doi.org/10.1093/neuonc/noac123

Burke MJ; Ziegler DS; Bautista F; Attarbaschi A; Gore L; Locatelli F; M. O'Brien M; Pauly M; Kormany WN; Tian S; Morris CL; Baruchel A, 2022, 'Phase 1b study of carfilzomib with induction chemotherapy in pediatric relapsed/refractory acute lymphoblastic leukemia', Pediatric Blood and Cancer, 69, http://dx.doi.org/10.1002/pbc.29999

van Tilburg C; Jones DT; Schmidt R; Avula S; van Meeteren AS; Sehested A; Opocher E; Driever PH; Witt R; Ziegler D; Blackman S; Zhao X; Tsao L-P; Cox M; Hargrave D; Witt O, 2022, 'CTNI-30. LOGGIC/FIREFLY-2: A PHASE 3, RANDOMIZED TRIAL OF TOVORAFENIB VS. CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH NEWLY DIAGNOSED LOW-GRADE GLIOMA HARBORING AN ACTIVATING RAF ALTERATION', Neuro-Oncology, 24, pp. vii77 - vii78, http://dx.doi.org/10.1093/neuonc/noac209.295

Whitlock JA; Malvar J; Dalla-Pozza L; Goldberg JM; Silverman LB; Ziegler DS; Attarbaschi A; Brown PA; Gardner RA; Gaynon PS; Hutchinson R; Huynh VT; Jeha S; Marcus L; Messinger Y; Schultz KR; Cassar J; Locatelli F; Zwaan CM; Wood BL; Sposto R; Gore L, 2022, 'Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR)', Pediatric Blood and Cancer, 69, http://dx.doi.org/10.1002/pbc.29901

Gereis J; Hetherington K; Ha L; Robertson EG; Ziegler DS; Barlow-Stewart K; Tucker KM; Marron JM; Wakefield CE, 2022, 'Parents’ understanding of genome and exome sequencing for pediatric health conditions: a systematic review', European Journal of Human Genetics, 30, pp. 1216 - 1225, http://dx.doi.org/10.1038/s41431-022-01170-2

Hetherington K; Wakefield CE; Kunalan KPK; Donoghoe MW; McGill BC; Fardell JE; Daly R; Deyell RJ; Ziegler DS, 2022, 'Quality of Life (QoL) of Children and Adolescents Participating in a Precision Medicine Trial for High-Risk Childhood Cancer', Cancers, 14, http://dx.doi.org/10.3390/cancers14215310

Gargett T; Ebert LM; Truong NTH; Kollis PM; Sedivakova K; Yu W; Yeo ECF; Wittwer NL; Gliddon BL; Tea MN; Ormsby R; Poonnoose S; Nowicki J; Vittorio O; Ziegler DS; Pitson SM; Brown MP, 2022, 'GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma', Journal for Immunotherapy of Cancer, 10, http://dx.doi.org/10.1136/jitc-2022-005187

Tsai JW; Cejas P; Wang DK; Patel S; Wu DW; Arounleut P; Wei X; Zhou N; Syamala S; Dubois FPB; Crane A; Pelton K; Vogelzang J; Sousa C; Baguette A; Chen X; Condurat AL; Dixon-Clarke SE; Zhou KN; Lu SD; Gonzalez EM; Chacon MS; Digiacomo JJ; Kumbhani R; Novikov D; Hunter J; Tsoli M; Ziegler DS; Dirksen U; Jager N; Balasubramanian GP; Kramm CM; Nathrath M; Bielack S; Baker SJ; Zhang J; McFarland JM; Getz G; Aguet F; Jabado N; Witt O; Pfister SM; Ligon KL; Hovestadt V; Kleinman CL; Long H; Jones DTW; Bandopadhayay P; Phoenix TN, 2022, 'FOXR2 Is an Epigenetically Regulated Pan-Cancer Oncogene That Activates ETS Transcriptional Circuits', Cancer Research, 82, pp. 2980 - 3001, http://dx.doi.org/10.1158/0008-5472.CAN-22-0671

Deblois S; Zhu L; Mastropasqua B; Thibaudeau S; Ziegler D; Pomp A, 2022, 'The clinical effectiveness and safety of intravenous unfractionated heparin following digital replantation and revascularization: A narrative systematic review', Microsurgery, 42, pp. 622 - 630, http://dx.doi.org/10.1002/micr.30895

Lazow MA; Nievelstein MT; Lane A; Bandopadhayhay P; DeWire-Schottmiller M; Fouladi M; Glod JW; Greiner RJ; Hoffman LM; Hummel TR; Kilburn L; Leary S; Minturn JE; Packer R; Ziegler DS; Chaney B; Black K; de Blank P; Leach JL, 2022, 'Volumetric endpoints in diffuse intrinsic pontine glioma: p correlations in the International DIPG/DMG Registry', Neuro Oncology, 24, pp. 1598 - 1608, http://dx.doi.org/10.1093/neuonc/noac037

Sacks E; Finlayson K; Brizuela V; Crossland N; Ziegler D; Sauvé C; Langlois ÉV; Javadi D; Downe S; Bonet M, 2022, 'Factors that influence uptake of routine postnatal care: Findings on women’s perspectives from a qualitative evidence synthesis', Plos One, 17, http://dx.doi.org/10.1371/journal.pone.0270264

Hunter JD; Robertson EG; Hetherington K; Ziegler DS; Marshall GM; Kirk J; Marron JM; Denburg AE; Barlow-Stewart K; Warby M; Tucker KM; Lee BM; O’Brien TA; Wakefield CE; O'Brien T, 2022, 'What’s in a Name? Parents’ and Healthcare Professionals’ Preferred Terminology for Pathogenic Variants in Childhood Cancer Predisposition Genes', Journal of Personalized Medicine, 12, pp. 1327, http://dx.doi.org/10.3390/jpm12081327

Lamoureux A-A; Fisher M; Lemelle L; Pfaff E; Kramm C; De Wilde B; Kazanowska B; Hutter C; Pfister SM; Sturm D; Jones D; Orbach D; Pierron G; Raskin S; Drilon A; Diamond E; Harada G; Zapotocky M; Ellezam B; Weil AG; Venne D; Barritault M; Leblond P; Coltin H; Hammad R; Tabori U; Hawkins C; Hansford JR; Meyran D; Erker C; McFadden K; Sato M; Gottardo NG; Dholaria H; Nørøxe DS; Goto H; Ziegler DS; Lin FY; Parsons DW; Lindsay H; Wong T-T; Liu Y-L; Wu K-S; Franson AF; Hwang E; Aguilar-Bonilla A; Cheng S; Cacciotti C; Massimino M; Schiavello E; Wood P; Hoffman LM; Cappellano A; Lassaletta A; Van Damme A; Llort A; Gerber NU; Ceruso MS; Bendel AE; Skrypek M; Hamideh D; Mushtaq N; Walter A; Jabado N; Alsahlawi A; Farmer J-P; Abadi CC; Mueller S; Mazewski C; Aguilera D; Robison N; O’Halloran K; Abbou S; Berlanga P; Geoerger B; Øra I; Moertel CL; Razis ED; Vernadou A; Doz F; Laetsch TW; Perreault S, 2022, 'HGG-11. Clinical characteristics and clinical evolution of a large cohort of pediatric patients with primary central nervous system (CNS) tumors and tropomyosin receptor kinase (TRK) fusion.', Neuro-Oncology, 24, pp. i61 - i62, http://dx.doi.org/10.1093/neuonc/noac079.226

Back to profile page